# Safety and Efficacy of Gabapentin in Diabetic Peripheral Neuropathy

> **NCT00712439** · PHASE2 · COMPLETED · sponsor: **Depomed** · enrollment: 147 (actual)

## Conditions studied

- Diabetic Peripheral Neuropathy

## Interventions

- **DRUG:** Gabapentin Extended Release tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00712439
- **Lead sponsor:** Depomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2006-11
- **Final completion:** 2006-12
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00712439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00712439, "Safety and Efficacy of Gabapentin in Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00712439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*